BioElectronics Corp., Product Pipeline Analysis, 2019 Update - Use of Pulsed Shortwave Electromagnetic Field Therapy Technology for the Development of its Products - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "BioElectronics Corp (BIEL) - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

BioElectronics Corp (BioElectronics) is a provider of non-invasive electroceuticals devices. It develops, manufactures and markets disposable, drug-free and non-invasive pain therapy devices for treating chronic pains and inflammation. The company' product portfolio include ActiPatch for the treatment for musculoskeletal pain relief; Allay, a menstrual pain therapy; Smart Insole for the treatment of heel pain; HealFast, a device developed for treating pain in dogs, cats and horses, and RecoveryRx, for relief from pain from postoperative recovery and chronic wounds. The company uses its pulsed shortwave electromagnetic field therapy technology for the development of its products. It offers products to hospitals and clinics through a network of wholesale distributors throughout the world. BioElectronics is headquartered in Frederick, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company BioElectronics Corp
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

• BioElectronics Corp Company Overview
• BioElectronics Corp Company Snapshot
• BioElectronics Corp Pipeline Products and Ongoing Clinical Trials Overview
• BioElectronics Corp - Pipeline Analysis Overview
• Business Description
• BioElectronics Corp - Key Facts
• BioElectronics Corp - Major Products and Services
• BioElectronics Corp Pipeline Products by Development Stage
• BioElectronics Corp Ongoing Clinical Trials by Trial Status
• BioElectronics Corp Pipeline Products Overview
• Actipatch - Expanded Indications
• Actipatch - Expanded Indications Product Overview
• Actipatch - Expanded Indications Clinical Trial
• Allay Menstrual Pain Relief Patch
• Allay Menstrual Pain Relief Patch Product Overview
• Allay Menstrual Pain Relief Patch Clinical Trial
• RecoveryRx - Breast Augmentation(OTC)
• RecoveryRx - Breast Augmentation(OTC) Product Overview
• RecoveryRx - Post Operative Edema (OTC)
• RecoveryRx - Post Operative Edema (OTC) Product Overview
• BioElectronics Corp - Key Competitors
• BioElectronics Corp - Key Employees
• BioElectronics Corp - Locations And Subsidiaries
• Head Office
• Recent Developments
• BioElectronics Corp, Recent Developments
• Oct 07, 2019: BioElectronics founder and CEO Andrew J. Whelan has died suddenly
• Oct 02, 2019: BioElectronics announces publication of a study of the ActiPatch medical device as an effective long-term treatment for chronic pain
• Aug 20, 2019: BioElectronics files FDA510(k) application for musculoskeletal pain complaints; clinical data demonstrates superior drug free pain relief to prescription strength NSAID drug
• Jul 01, 2019: BioElectronics announces FDA market clearance for its non-opioid postoperative pain therapy
• Jun 03, 2019: BioElectronics announces publication of study verifying the effectiveness of its ActiPatch Medical Device on Chronic Pain
• May 22, 2019: BioElectronics announces withdrawal and planned resubmission of 510(k) for general musculoskeletal pain
• Apr 23, 2019: BioElectronics Responds to FDA's 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications
• Mar 14, 2019: Northwest Specialty Hospital now offering electroceutical alternative to opioids in clinical practice
• Mar 08, 2019: BioElectronics announces back pain clinical study with leading Australian pain center
• Feb 12, 2019: BioElectronics files FDA applications for treatment of musculoskeletal & postoperative pain
• Appendix
• Methodology
• About the Author
• Contact Us
• Disclaimer

Companies Mentioned

• NeuroMetrix Inc
• Regenesis Biomedical Inc
• Nevro Corp
• Stimwave Technologies Inc
• Avanos Medical Inc

For more information about this company profile visit https://www.researchandmarkets.com/r/92fl1r